U.S. market Closed. Opens in 2 hours 1 minute

PRFX | PainReform Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/A86.00KN/AN/AN/AN/A
Cost of Revenue15.00K15.00K7.00KN/A1.00KN/A
Gross Profit-15.00K71.00K-7.00KN/A-1.00KN/A
Operating Expenses9.58M8.87M7.21M1.67M689.00K500.00K
Selling, General & Admin3.55M4.45M4.35M1.32M553.00K277.00K
Research & Development6.04M4.42M2.86M354.00K136.00K223.00K
Other Operating ExpensesN/AN/AN/AN/AN/AN/A
Operating Income-9.58M-8.87M-7.21M-1.67M-689.00K-500.00K
Other Expenses / Income248.00K86.00K-32.00K-2.16M-590.00K-3.00K
Before Tax Income-9.34M-8.78M-7.24M-3.83M-1.28M-828.00K
Income Tax Expenses8.00K9.00K6.00K220.00K541.00K4.00K
Net Income-9.34M-8.79M-7.25M-4.05M-1.82M-828.00K
Interest Expenses384.00K61.00K10.00K987.00K541.00K324.00K
Basic Shares Outstanding218.00K1.07M981.22K1.17M930.79K579.55K
Diluted Shares Outstanding218.15K1.07M981.22K1.17M930.79K579.55K
EBITDA-9.57M-8.71M-7.21M-1.74M-737.00K-501.00K
EBITDA Margin0.00%-10,124.42%0.00%0.00%0.00%0.00%
EBIT-8.95M-8.72M-7.23M-2.85M-738.00K-500.00K
EBIT Margin0.00%-10,141.86%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙